Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rosa M. Sanchez-Hernandez"'
Autor:
Sofía Perez-Calahorra, Martin Laclaustra, Victoria Marco-Benedi, Xavier Pinto, Rosa M. Sanchez-Hernandez, Núria Plana, Emilio Ortega, Francisco Fuentes, Fernando Civeira
Publikováno v:
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-6 (2019)
Abstract Background There is no randomized clinical trials with recurrence of atherosclerotic cardiovascular disease (ASCVD) as a major outcome with rosuvastatin. In order to analyze potential differences in the clinical response to atorvastatin and
Externí odkaz:
https://doaj.org/article/15fd82c77b654964b32d932f46ddf00d
Autor:
Victoria Marco-Benedí, Rosa M. Sánchez-Hernández, José Luis Díaz, Estíbaliz Jarauta, Manuel Suárez-Tembra, Xavier Pintó, Carlos Morillas, Núria Plana, Juan Pedro-Botet, Fernando Civeira
Publikováno v:
Lipids in Health and Disease, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have represented an important change in the management of hypercholesterolemia, although, until now, they have barely been used. Without PCSK9i, many patients with
Externí odkaz:
https://doaj.org/article/7f0a1bd67b9144df8b8a49e0171c1080
Autor:
Ana M. González-Lleó, Rosa M. Sánchez-Hernández, Núria Plana, Daiana Ibarretxe, Pere Rehues, Josep Ribalta, Dídac Llop, Ana M. Wägner, Lluís Masana, Mauro Boronat
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-8 (2024)
Abstract Background The diabetogenic effect of statins has been well established by clinical trials, Mendelian randomisation studies and meta-analyses. According to large clinical trials, PCSK9 inhibitors (PCSK9i) have no deleterious impact on glucos
Externí odkaz:
https://doaj.org/article/c12da2f5cf514766ace3a5b5e220a9af
Autor:
Nicolás M. Suárez, Shifa Jebari-Benslaiman, Roberto Jiménez-Monzón, Asier Benito-Vicente, Yeray Brito-Casillas, Laida Garcés, Ana M. González-Lleo, Antonio Tugores, Mauro Boronat, César Martin, Ana M. Wägner, Rosa M. Sánchez-Hernández
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 14, p 11319 (2023)
The p.(Tyr400_Phe402del) mutation in the LDL receptor (LDLR) gene is the most frequent cause of familial hypercholesterolaemia (FH) in Gran Canaria. The aim of this study was to determine the age and origin of this prevalent founder mutation and to e
Externí odkaz:
https://doaj.org/article/c1d7477560414ecb82a1f4bf2b208f71